[1]宋林芳.大肠杆菌K5多糖对糖尿病视网膜病变小鼠视网膜新生血管形成作用的研究[J].眼科新进展,2017,37(11):1032-1035.[doi:10.13389/j.cnki.rao.2017.0261]
　SONG Lin-Fang.Effect of E.coli K5 polysaccharide on retinal neovascularization in mice with diabetic retinopathy[J].Recent Advances in Ophthalmology,2017,37(11):1032-1035.[doi:10.13389/j.cnki.rao.2017.0261]
点击复制

大肠杆菌K5多糖对糖尿病视网膜病变小鼠视网膜新生血管形成作用的研究/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
37卷
期数:
2017年11期
页码:
1032-1035
栏目:
实验研究
出版日期:
2017-11-05

文章信息/Info

Title:
Effect of E.coli K5 polysaccharide on retinal neovascularization in mice with diabetic retinopathy
作者:
宋林芳
455000　河南省安阳市,安阳市眼科医院
Author(s):
SONG Lin-Fang
Anyang Eye Hospital of Henan Province，Anyang 455000，Henan Province，China
关键词:
K5多糖; 糖尿病视网膜病变; 血管形成
Keywords:
K5 polysaccharide; diabetic retinopathy; neovascularization generation
分类号:
R774
DOI:
10.13389/j.cnki.rao.2017.0261
文献标志码:
A
摘要:
目的　探究大肠杆菌K5多糖对糖尿病视网膜病变小鼠视网膜新生血管形成的影响。方法　发酵培养大肠杆菌K5菌株，对培养液进行分离纯化制备K5多糖，并分析K5多糖的纯度；雄性ICR小鼠被随机分为正常组、模型组和干预组，其中正常组是健康小鼠，而模型组和干预组均使用链脲佐菌素建立糖尿病小鼠模型，干预组于造模后使用K5多糖干预4周，造模后8周各组取小鼠眼球组织，行HE染色及视网膜铺片ADPase染色；采用Real-time PCR和Western blotting检测各组小鼠眼球组织血管内皮生长因子（vascular endothelial growth factor，VEGF）及基质金属蛋白酶-2（matrix metalloproteinase，MMP-2）的表达情况。结果　HPLC结果显示制备的K5多糖纯度在95%以上；HE染色及ADPase染色结果显示正常组小鼠视网膜只见少量血管，模型组小鼠视网膜血管数目显著高于正常组，而干预组小鼠视网膜血管数目较模型组显著下降（P<0.05）；Real-time PCR和Western blot结果显示，模型组小鼠眼球组织VEGF和MMP-2的mRNA及蛋白表达水平显著高于正常组（均为P<0.05），而干预组VEGF和MMP-2的mRNA及蛋白表达水平显著低于模型组（均为P<0.05）。结论　大肠杆菌K5多糖能够抑制糖尿病视网膜病变小鼠视网膜新生血管形成，其作用机制可能与抑制VEGF及MMP-2的表达有关。
Abstract:
Objective　To explore the influence of E.coli K5 polysaccharide on retinal neovascularization in mice of diabetic retinopathy.Methods　E.coli K5 strain was cultivated by fermentation and the supernatant was used to prepare K5 polysaccharide for analyze its purity by high performance liquid chromatography (HPLC).Moreover，male ICR mice were divided into normal group，model group and K5 polysaccharide treatment group (treatment group for short).The mice in the normal group were healthy and left untreated，while the mice in the model group and treatment group were administrated with streptozotocin to establish diabetic model，and the treatment group received K5 polysaccharide 4 weeks after the successful modeling.Then the eyeball tissues in the three groups were collected 8 weeks after modeling for HE staining and ADPase staining，and real-time PCR and Western blot were used to detect the expression of vascular endothelial growth factor (VEGF) and matrix metalloproteinase-2 (MMP-2) in eyeball tissues.Results　HPLC results showed that the purity of K5 polysaccharide exceeded 95%.HE staining and ADPase staining suggested that a few of new vessels were observed，and the number of vessels in the model group was significantly higher than those in the normal group，while the treatment group was significantly lower than the model group (P<0.05).Real-time and Western blot showed that the expression of VEGF and MMP-2 mRNA and protein in the model group were significantly higher than those in the normal group，while the treatment group was significantly lower than the model group (P<0.05).Conclusion　E.coli K5 polysaccharide can inhibit the retinal neovascularization generation in mice with diabetic retinopathy，and the mechanism of its action may be associated with the suppressed expression of VEGF and MMP-2.

参考文献/References:

［1］　CHOU J，ROLLINS S，FAWZI AA.Role of endothelial cell and pericyte dysfunction in diabetic retinopathy：review of techniques in rodent models［M］//Retinal Degenerative Diseases.Berlin：Springer Netherlands，2014：669-675.
［2］　OSAADON P，FAGAN XJ，LIFSHITZ T，LEVY J.A review of anti-VEGF agents for proliferative diabetic retinopathy［J］.Eye，2014，28（5）：510.
［3］　ZHENG Y，ZHANG X，GUO J.Application in ophthalmology and otorhinolaryngology［M］//Dan Shen （Salvia Miltiorrhiza） in Medicine.Berlin：Springer Netherlands，2015：75-81.
［4］　YU QQ，YAO Y，ZHU J，FU DH，XIE TH，YIN L，et al.Association between a 27-bp variable number of tandem repeat polymorphism in intron 4 of the eNOS gene and risk for diabetic retinopathy Type 2 diabetes mellitus：A meta-analysis［J］.Curr Eye Res，2014，39（10）：1052-1058.
［5］　MOHAMMAD G，JOMAR D，SIDDIQUEI MM，ALAM K，ABU EL-ASRAR AM.High-mobility group box-1 protein mediates the regulation of signal transducer and activator of transcription-3 in the diabetic retina and in human retinal Müller cells［J］.Ophthalmic Res，2017，57（3）：150-160.
［6］　EASTLAKE K，BANERJEE PJ，ANGBOHANG A，CHARTERIS DG，KHAW PT，LIMB GA.Müller glia as an important source of cytokines and inflammatory factors present in the gliotic retina during proliferative vitreoretinopathy［J］.Glia，2016，64（4）：495-506.
［7］　郏亚静，南文滨，秦靖雯，魏向娟，郭双，李武山，等.普鲁兰多糖纳米粒作为靶向抗肿瘤药物载体的研究进展［J］.新乡医学院学报，2016，33（1）：9-11.
JIA YY，NAN WB，QIN JW，WEI XJ，GUO S，LI WS，et al.The progress of the study on the delivery of the polysaccharide nanoparticles in the targeted anti-tumor drug carrier［J］.J Xinxiang Medical Univ，2016，33（1）：9-11.
［8］　徐发林，庄方莉，白琼丹，段佳佳.细菌脂多糖对不同成熟度新生小鼠脑发育的影响［J］.实用儿科临床杂志，2012，27(8)：611-613，616.
XU FL，ZHUANG FL，BAI QD，DUAN JJ.Effects of bacterial lipopolysaccharide on brain development of neonatal mice at different maturity levels［J］.J Appl Clin Pediatr，2012，27(8)：611-613，616.
［9］　DUFRESNE A，CASTANO J.Polysaccharide nanomaterial reinforced starch nanocomposites：A review［J］.Starch-Strke，2017，69（1-2）：116.
［10］　WANG PC，ZHAO S，YANG BY，WANG QH，KUANG HX.Anti-diabetic polysaccharides from natural sources：A review［J］.Carbohydr Polym，2016，148：86-97.
［11］　WANG Y，QIN S，PEN G，CHEN D，HAN C，MIAO CR，et al.Potential ocular protection and dynamic observation of Polygonatum sibiricum polysaccharide against streptozocin-induced diabetic rats’ model［J］.Exp Biol Med，2017，242（1）：92-101.
［12］　RUSNATI M，VICENZI E，DONALISIO M，ORESTEET P，LANDOLFO S，LEMBO D.Sulfated K5 escherichia coli polysaccharide derivatives：a novel class of candidate antiviral microbicides［J］.Pharmacol Therap，2009，123（3）：310-322.
［13］　TING SW，CHEUNG CM，WONG TY.Diabetic retinopathy：global prevalence，major risk factors，screening practices and public health challenges：a review［J］.Clin Exp Ophthalmol，2016，44（4）：260-277.
［14］　STITT AW，CURTIS TM，CHEN M，MEDINA RJ，MCKAY GJ，JENKINS A，et al.The progress in understanding and treatment of diabetic retinopathy［J］.Prog Ret Eye Res，2015，51：156-186.
［15］　COLE ED，NOVAIS EA，LOUZADA RN，WAHEED NK.Contemporary retinal imaging techniques in diabetic retinopathy：a review［J］.Clin Exp Ophthalmol，2016，44（4）：289-299.
［16］　VAZPEREIRA S，ZARRANZVENTURA J，SIM DA，KEANE PA，SMITH R，EGAN CA，et al.Optical coherence tomography features of active and inactive retinal neovascularization in proliferative diabetic retinopathy［J］.Retina，2016，36（6）：1132-1142.
［17］　CHO H，ALWASSIA AA，REGIATIERI CV，ZHANG JY，BAUMAL C，WAHEED N，et al.Retinal neovascularization secondary to proliferative diabetic retinopathy characterized by spectral domain optical coherence tomography［J］.Retina，2013，33（3）：542-547.
［18］　MADDINENI J，JESKE WP，BALTASAR F，CORNELLI U，MANONI M，HOPPENSTEADT DA，et al.Modulatory effects of escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets：flow cytometric analysis［J］.Clin Appl Thromb Hemost，2006，12（3）：311.
［19］　LEMBO D，DONALISIO M，RUSNATI M，BUGATTI A，CORNAGLIA M，CAPPELLO P，et al.Sulfated K5 escherichia coli polysaccharide derivatives as wide-range inhibitors of genital types of human papillomavirus［J］.Antimicrob Agents Chemother，2008，52（4）：1374-1381.
［20］　谢秀雯，周建强，崔红平.VEGF在糖尿病视网膜病变发病机制中作用的研究新进展［J］.国际眼科杂志，2011，11（2）：282-285.
XIE XW，ZHOU JQ，CUI HP.Latest progress of VEGF in the pathogenesis of diabetic retinopathy［J］.Int Eye Sci，2011，11（2）：282-285.
［21］　苟文军，吕红彬.血管形成促进因子在糖尿病视网膜病变新生血管形成中的作用［J］.眼科新进展，2010，30（10）：988-990.
GOU WJ，LV HB.Efficacy of angiogenesis-promoting factors on neovascularization of DR［J］.Rec Adv Ophthalmol，2010，30（10）：988-990.

相似文献/References:

[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.

更新日期/Last Update: 2017-11-01